<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
-----
PharmHouse
----------------------------------
(Name of Issuer)
Common Stock Par Value .01
----------------------------------
(Title of Class of Securities)
717137103
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /.
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent
of the class of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership of five percent
or less of such class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
(Continued on following page(s))
Page 1 of Pages
---
<PAGE>
CUSIP No. 13G Page of Pages
--------- --- ---
Hemisphere Trading Co. 5796 Shelby Oaks Drive Suite 12 Memphis TN 38134
- -----------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
621505218
- -----------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -----------------------------------------------------------------------------
(3) SEC Use Only
- -----------------------------------------------------------------------------
(4) Citizenship or Place of Organization
TN
- -----------------------------------------------------------------------------
Number of Shares (5) Sole Voting
Beneficially Power
Owned by ------------------------------------------------
Each Reporting (6) Shared Voting
Person With Power 201,600
------------------------------------------------
(7) Sole Dispositive
Power
------------------------------------------------
(8) Shared Dispositive
Power 201,600
- -----------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
201,600
- -----------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -----------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
.0903
- -----------------------------------------------------------------------------
(12) Type of Reporting Person*
investment advisor
- -----------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Page of Pages
--- ---
ITEM 1(A). NAME OF ISSUER
PharmHouse
- -----------------------------------------------------------------------------
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
860 Broadway NYC NY 10003
- -----------------------------------------------------------------------------
ITEM 2(A). NAME OF PERSON(S) FILING
Brad Arberg, Hemisphere Trading Co
- -----------------------------------------------------------------------------
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
5796 Shelby Oaks Drive St. 12 MEMPHIS TN 38134
- -----------------------------------------------------------------------------
ITEM 2(C). CITIZENSHIP
TN
- -----------------------------------------------------------------------------
ITEM 2(D). TITLE OF CLASS OF SECURITIES
Common Stock
- -----------------------------------------------------------------------------
ITEM 2(E). CUSIP NUMBER
717137103
- -----------------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B),
CHECK WHETHER THE PERSON FILING IS A
(a) / / Broker or Dealer registered under Section 15 of the Act
(b) / / Bank as defined in section 3(a)(6) of the Act
(c) / / Insurance Company as defined in section 3(a)(19) of the Act
(d) / / Investment Company registered under section 8 of the Investment
Company Act
(e) /X/ Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
(f) / / Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F)
(g) / / Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G)
(Note: See Item 7)
(h) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(H)
<PAGE>
Page of Pages
--- ---
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned:
201,600
-------------------------------------------------------------------------
(b) Percent of Class:
.0903
-------------------------------------------------------------------------
(c) Number of shares as to which such person has:
201,600
(i) sole power to vote or to direct the vote
201,600
---------------------------------------------------------------
(ii) shared power to vote or to direct the vote
---------------------------------------------------------------
(iii) sole power to dispose or to direct the disposition of
---------------------------------------------------------------
(iv) shared power to dispose or to direct the disposition of
---------------------------------------------------------------
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following. / /
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
- -----------------------------------------------------------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
- -----------------------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
- -----------------------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
- -----------------------------------------------------------------------------
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not have
the effect of changing or influencing the control of the issuer of such
securities and were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete
and correct.
AUG 8, 1996
--------------------------------------
(Date)
/s/ BRAD ARBERG
--------------------------------------
(Signature)
Brad Arberg
--------------------------------------
(Name/Title)
